2017-05-16T14:02:30-05:00 2016-06-30 ERNST & YOUNG US LLP 2100 ONE PPG PLACE PITTSBURGH PA 15222 990 2015-07-01 900593925 The Subsidiaries of the Institute FOR TRANSFUSION MEDICINE % MARK J GIAQUINTO INST 4122097300 875 GREENTREE RD PC5 PITTSBURGH PA 15220 MARK J GIAQUINTO PRESIDENT & CFO, BSF 4122097302 2017-04-28 2015 2021-01-29 14:40:06Z X CHARLES WILCOX SAME AS C ABOVE PITTSBURGH PA 15220 199175797 true true 5645 X www.itxm.org X PA TO PROVIDE BEST IN CLASS BLOOD PRODUCTS AND CLINICAL SERVICES TO MEET THE NEEDS OF THE HEALTHCARE COMMUNITY, PATIENTS & OUR DONORS THROUGH ADVANCED TRANSFUSION MEDICINE PRACTICES. 16 12 1139 162 25000 24000 448649 584869 194701254 191016919 6762071 6418676 1104174 1095155 203016148 199115619 8924037 4039429 0 0 65578846 65855027 0 0 0 122635761 127217031 197138644 197111487 5877504 2004132 295803842 286020449 20391059 18093534 275412783 267926915 X ITXM'S MISSION IS TO PROVIDE BEST IN CLASS BLOOD PRODUCTS AND CLINICAL SERVICES TO MEET THE NEEDS OF THE HEALTHCARE COMMUNITY, PATIENTS AND OUR DONORS THROUGH ADVANCED TRANSFUSION MEDICINE PRACTICES. ITXM'S VISION IS TO BE THE PREMIER PROVIDER OF BLOOD TRANSFUSION PRACTICES BY DELIVERING INNOVATIVE INDUSTRY LEADING SOLUTIONS THAT ENSURE THE HIGHEST QUALITY PRODUCTS AND SERVICES, OPERATING EFFICIENCIES, DONOR SATISFACTION AND IMPROVED PATIENT CARE RESULTING IN THE ACHIEVEMENT OF OUR MISSION. ITXM'S MISSION AND VISION ARE SUPPORTED BY OUR VALUES OF STEWARDSHIP, INTEGRITY, ACCOUNTABILITY, RESPECT, EXCELLENCE AND INNOVATION. false false 100427579 0 103019610 THE PRIMARY PURPOSE OF CENTRAL BLOOD BANK, LIFESOURCE AND VIRGINIA BLOOD SERVICES IS TO PROMOTE PUBLIC PARTICIPATION IN A COMMUNITY-BASED BLOOD PROGRAM. A SUCCESSFUL BLOOD PROGRAM HELPS TO ASSURE AN ADEQUATE AND SAFE BLOOD SUPPLY TO THOSE MEMBERS OF THE COMMUNITY IN NEED. IN ADDITION TO HUMAN BLOOD COLLECTIONS, THE BLOOD BANKS ARE ACTIVELY INVOLVED WITH BONE MARROW AND APHERESIS TISSUE COLLECTIONS. DONOR COUNSELING IS ALSO AN IMPORTANT SERVICE PROVIDED TO THE DONATING PUBLIC. 31277048 0 42714306 CLINICAL SERVICES PROVIDES BLOOD AND BLOOD-RELATED DIAGNOSTIC TESTS AND PROCEDURES TO ENSURE THAT THE UNITS OF DONATED BLOOD ARE COMPATIBLE WITH SPECIFIC PATIENTS. CLINICAL SERVICES ALSO OPERATES THE ONLY PUBLIC CORD BLOOD BANK IN THE CHICAGO AREA. ITXM DIAGNOSTICS PROVIDES TESTING SERVICES AND UNDERTAKES RESEARCH AND EDUCATIONAL ACTIVITIES WITH RESPECT TO BLEEDING AND CLOTTING DISORDERS AND PROVIDES THERAPEUTIC APHERESIS SERVICES. 40072881 1810536 46296617 THE HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA PROVIDES MEDICAL SERVICES TO PERSONS WITH CONGENITAL BLEEDING AND CLOTTING DISORDERS AND WORKS TO DEVELOP AND SUPPORT EDUCATIONAL, RESEARCH AND THERAPEUTIC SERVICES. THEY OPERATE A 340B DRUG DISTRIBUTION PROGRAM WHICH PROVIDES FUNDS TO SUPPORT PERSONNEL, PERFORM OUTREACH CLINICS, ENHANCE COMMUNICATION VIA WEB SITE AND BROCHURES, IMPROVE BUSINESS OPERATIONS AND CLINICAL CARE THROUGH THE IMPLEMENTAION OF ELECTRONIC MEDICAL RECORDS, SUPPORT OTHER 504(C)(3) ORGANIZATIONS THAT PROVIDE EDUCATION AND CAMP OPPORTUNITIES FOR PATIENTS. 4024958 3579853 0 175802466 true true false true false false false false false false true true false false false true false true false false true false false false false false false true false true false false false false false false false false true false false false false true true false false false true 108 0 true 1139 true true true false false false false false false false false false X 16 12 false false false false true true false true true false false true true true true true true true true false IL PA VA X MARK J GIAQUINTO 4122097302 5 PARKWAY CENTER 875 GREENTREE ROAD PITTSBURGH PA 15220 TERRENCE BILKEY BSF CHAIRMAN 2.0 0.0 X X 8250 0 0 ROBERT OSTROWSKI BSF DIRECTOR 2.0 0.0 X 0 0 0 JAMES P COVERT CENTRAL BLOOD BANK, PRES & CEO 1.0 39.0 X X 0 618396 168793 MARK J GIAQUINTO CENTRAL BLOOD BANK SECY/TREAS 1.0 39.0 X X 0 347462 88256 DIANE MERKT CENTRAL BLOOD BANK VP 1.0 39.0 X X 0 281622 71452 LINDA HAHN ITXM CLINICAL SVCS VICE PRES 40.0 0.0 X X 283696 0 176291 ANDREA CORTESE HASSETT PHD ITXM DIAGNOSTICS VICE PRES 39.0 1.0 X X 233334 0 116100 FRANKLIN BONTEMPO MD DIAGNOSTICS DIRECTOR 40.0 0.0 X 116767 0 28241 MARGARET V RAGNI MD HCWP DIRECTOR 40.0 0.0 X 0 0 0 A KIM RITCHEY MD HCWP DIRECTOR 1.0 0.0 X 0 0 0 DARRELL TRIULZI MD HCWP DIRECTOR 1.0 0.0 X 0 0 0 EDWARD CHU MD HCWP CHAIR 1.0 0.0 X X 0 0 0 MARK GLADWIN MD HCWP DIRECTOR 1.0 0.0 X 0 0 0 MILES SIMON HCWP DIRECTOR (THROUGH 12/15) 1.0 0.0 X 0 0 0 JAMES P COVERT LIFESOURCE PRES & CEO 1.0 39.0 X X 0 0 0 JAMES P COVERT ITXM CLINICAL SVCS PRES & CEO 1.0 39.0 X X 0 0 0 JAMES P COVERT ITXM DIAGNOSTICS PRES & CEO 1.0 39.0 X X 0 0 0 JAMES P COVERT BSF PRES & CEO 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO LIFESOURCE SECY/TREAS 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO ITXM CLINICAL SVCS SECY/TREAS 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO ITXM DIAGNOSTICS SECY/TREAS 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO HCWP SECY/TREAS/DIRECTOR 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO BSF SECY/TREAS 1.0 39.0 X X 0 0 0 DIANE MERKT LIFESOURCE VP 1.0 39.0 X X 0 0 0 ALAN J DEAN BSF DIRECTOR 1.0 1.5 X 4500 15000 0 RICHARD STOVER BSF VICE CHAIR (EFFECT 06/16) 1.0 1.5 X X 5750 12000 0 MATTHEW SUHEY BSF DIRECTOR 1.0 0.0 X 8250 0 0 CHARLES H BRACKEN JR BSF DIRECTOR 1.0 1.5 X 4500 21500 0 DIANE MERKT HCWP DIRECTOR 1.0 39.0 X 0 0 0 JAMES P COVERT VBS PRES & CEO 1.0 39.0 X X 0 0 0 MARK J GIAQUINTO VBS SECY\TREAS 1.0 39.0 X X 0 0 0 DIANE MERKT VBS VP 1.0 39.0 X X 0 0 0 ANDREA CORTESE HASSETT PHD HCWP DIRECTOR 1.0 39.0 X 0 0 0 JAMES P COVERT HCWP CEO 1.0 39.0 X 0 0 0 MONA PAPARI LIFESOURCE MEDICAL DIRECTOR 40.0 0.0 X 244992 0 15633 MICHELE TYSARCZYK CENTRAL BLOOD BANK EXEC DIR 40.0 0.0 X 168500 0 53960 CHELSEA SHEPPARD MD VIRGINIA BLOOD SVCS MED DIR 40.0 0.0 X 198375 0 3224 ELEANOR BOENS VIRGINIA BLOOD SVCS HR DIR 40.0 0.0 X 164871 0 7807 JASON CRANE LS ASSOCIATE MEDICAL DIRECTOR 40.0 0.0 X 178116 0 39011 JAMES FITZGERALD CBBVP & COO (THROUGH 06/15) 10.0 30.0 X 0 169299 -3224 1619901 1465279 765544 28 true true false INCEPT CORPORATION 4150 BELDEN VILLAGE ST NW SUITE 2 CANTON OH 44718 TELERECRUITMENT SVCS 1302548 CREATIVE TESTING SOLUTIONS PO BOX 29871 PHOENIX AZ 85038 DONOR TESTING 13341439 GULD RESOURCE GROUP 3434 EDWARDS MILL ROAD 112-228 RALEIGH NC 27612 MEDIA ADVERTISING 426661 AMERICAN EXPEDITING COMPANY INC 801 NORTH PRIMOS AVENUE FOLCROFT PA 19032 SHIPPING 737843 SUMMITT FACILITIES MANAGEMENT 2241 HILLWOOD COURT LIZELLA GA 31052 FACILITIES MGMT SVCS 261833 26 431 269565 314873 294190 584869 BLOOD PRODUCTS & COMPONENTS 900099 97244694 97244694 FACTOR PROGRAM REVENUE 621400 46248956 46248956 BLOOD & BLOOD RELATED TESTING 900099 47523269 47523269 191016919 6395498 6395498 0 0 100527 43986 56541 0 56541 56541 39370 16192 23178 23178 23178 0 0 0 REVENUE FROM AFFILIATED ORGANIZATIONS 900099 831826 831826 REVENUE FROM RESEARCH 900099 128819 128819 ADVERTISING INCOME 900099 25000 25000 52969 52969 1038614 199115619 192030533 25000 6475217 4039429 4039429 0 0 0 665047 116767 548280 0 0 49485147 49485147 2929620 2929620 8149900 8149900 4625313 4625313 158504 158504 30104 30104 8041 8041 202289 202289 0 159225 159225 5102343 5102343 2221167 2221167 6655736 6655736 1581015 1581015 0 5467188 5467188 2182828 2182828 0 27826 27826 15701 15701 0 5895220 5895220 365507 365507 FACTOR PROGRAM EXPENSES 35202852 35202852 0 0 TESTING & LABORATORY SUPPLIES 32507771 32507771 0 0 ITXM SHARED SERVICES 20443012 0 20443012 0 BLOOD PRODUCTS & COMPONENTS 4782745 4782745 0 0 4207957 4207957 197111487 175802466 21309021 0 2992277 251593 0 0 38051 43978 18413199 20986394 0 0 0 0 0 0 6653142 6686038 691290 926941 114646666 51075745 63706979 63570921 0 0 188289030 182574413 0 0 179990 127994 14839884 10852177 295803842 286020449 16254171 16615000 3838835 1196786 298053 281748 0 0 0 0 0 0 0 0 0 0 0 0 20391059 18093534 X 217713181 204385915 57699602 63541000 0 0 275412783 267926915 295803842 286020449 2004132 -9490000 X false true X true true true X 6 17242 325632 458039 448649 584869 1834431 183574175 159552851 202368028 194701254 191016919 931213227 0 0 0 0 0 0 0 0 0 0 0 0 0 183591417 159878483 202826067 195149903 191601788 933047658 0 0 0 0 0 0 115243551 112635772 97989926 106983323 104964575 537817147 115243551 112635772 97989926 106983323 104964575 537817147 395230511 1560959 2460958 2770341 1935564 6496025 15223847 0 0 0 0 25000 25000 1560959 2460958 2770341 1935564 6521025 15248847 0 0 0 0 0 0 12980 800431 1183298 1074384 1013614 4084707 185165356 163139872 206779706 198159851 199136427 952381212 0.41499 0.40390 0.01601 0.01070 X false false false false false true false false false false false false false false false false false false false false false 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SCHEDULE A, PART III THE IRS EO BUSINESS MASTER FILE ERRONEOUSLY LISTS EACH OF THE ORGANIZATIONS INCLUDED IN THIS RETURN AS A SECTION 509(A)(3) SUPPORTING ORGANIZATION. WHILE SOME OF THE ORGANIZATIONS ARE IN FACT SECTION 509(A)(3) SUPPORTING ORGANIZATIONS (PLEASE SEE PART VI - INFORMATION ABOUT SUPPORTED ORGANIZATIONS BELOW), A MAJORITY OF THE ORGANIZATIONS HAVE IRS DETERMINATION LETTERS INDICATING THAT THEY ARE PUBLICLY SUPPORTED ORGANIZATIONS DESCRIBED IN SECTION 509(A)(2). THEREFORE SCHEDULE A, PART III IS BEING COMPLETED FOR THESE SECTION 509(A)(2) ORGANIZATIONS. SCHEDULE A, PART III, LINE 12 THE AMOUNT ON LINE 12 DOES NOT INCLUDE CAPITAL GAINS IN THE AMOUNT OF: 2011 $7,333 2012 $337,871 2013 $6,461 2014 $(592) 2015 $23,178 SCHEDULE A, PART IV, SECTION A, LINE 1 CENTRAL BLOOD BANK IS THE ONLY SUPPORTED ORGANIZATION LISTED BY NAME IN BSF'S ORGANIZING DOCUMENTS. ALL OTHER SUPPORTED ORGANIZATIONS ARE IDENTIFIED BY CLASS - AFFILIATES DESCRIBED IN SECTIONS 509(A)(1) AND 509(A)(2). SCHEDULE A, PART IV, SECTION A, LINE 6 BSF'S ORGANIZING DOCUMENTS PERMIT BSF TO PROVIDE FUNDS TO FURTHER THE ERECTION, ESTABLISHMENT, ORGANIZATION, EQUIPMENT, OPERATION, MANAGEMENT, AND MAINTENANCE OF FACILITIES FOR THE COLLECTION AND PROVISION OF HUMAN BLOOD, ITS COMPONENTS AND DERIVATIVES, AND HUMAN ORGANS AND TISSUES TO HOSPITALS AND OTHER INSTITUTIONS WHOSE USE THEREOF ARE DIRECTED TOWARD PATIENT CARE, INCLUDING THE PROVISION OF EDUCATIONAL LABORATORY, RESEARCH AND THERAPEUTIC SERVICES. GRANTS MADE PURSUANT TO THIS PROVISION ARE DETAILED IN SCHEDULE I. SCHEDULE A, PART IV, SECTION C, LINE 1 THE MANAGEMENT OF BSF IS VESTED IN THE SAME PERSONS THAT CONTROL AND MANAGE EACH OF BSF'S SUPPORTED ORGANIZATIONS. THE PRESIDENT/CEO AND THE SECRETARY/TREASURER OF ITXM, THE PARENT ORGANIZATION OF BSF AND BSF'S SUPPORTED ORGANIZATIONS, ALSO SERVE AS OFFICERS FOR BSF AND EACH OF BSF'S SUPPORTED ORGANIZATIONS. FURTHERMORE, AS THE COMMON PARENT ORGANIZATION OF BSF AND BSF'S SUPPORTED ORGANIZATIONS, ITXM HAS THE POWER TO REVIEW AND RATIFY BSF AND BSF'S SUPPORTED ORGANIZATIONS' ACTIVITIES AND MAJOR CORPORATE ACTIONS. PART VI SCHEDULE A, PART I - INFORMATION ABOUT SUPPORTED ORGANIZATIONS THE BLOOD SCIENCE FOUNDATION PROVIDES GRANTS TO TAX EXEMPT ORGANIZATIONS OTHER THAN ITS SUPPORTED ORGANIZATIONS THAT FURTHER THE CHARITABLE MISSIONS OF ITS SUPPORTED ORGANIZATIONS AND WHICH ARE DESCRIBED IN SECTION 501(C)(3) AND SECTION 509(A)(1) OR 509(A)(2). SCHEDULE A, PART I - INFORMATION ABOUT SUPPORTED ORGANIZATIONS (CONT'D.) TYPE OF LISTED IN % NAME EIN ORG GOV DOC SUPPORT CENTRAL BLOOD BANK 25-1055312 09 YES 0 LIFESOURCE BLOOD SERVICES 36-3492969 09 NO 0 VIRGINIA BLOOD SERVICES 54-0959121 09 NO 0 ITXM CLINICAL SERVICES 25-1839168 09 NO 0 ITXM DIAGNOSTICS 03-0497690 09 NO 0 HEMOPHILIA CENTER OF WESTERN PA 25-1562716 03 NO 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false true 202289 false false 202289 false SCHEDULE C, PART II-B, LINE 1G A CONSULTANT IS COMPENSATED TO ACT AS THE EXECUTIVE DIRECTOR AND LEGISLATIVE COORDINATOR FOR THE ILLINOIS COALITION OF COMMUNITY BLOOD CENTERS. THE CONSULTANT RESEARCHES DONOR TRENDS AND WAYS TO IMPROVE BLOOD DONATIONS AND ACTS AS AN ADVOCATE FOR THE SUCCESSFUL PASSAGE OF LEGISLATION THAT WILL HELP INCREASE BLOOD DONATIONS. A LEGAL FIRM IS RETAINED FOR REPRESENTATION ON MATTERS AFFECTING PUBLIC POLICY WHICH INVOLVES LOBBYING CONGRESS TO RECOMMEND TO HRSA TO GRANT AN EXCEPTION ON THE USE OF 340B FUNDS FOR A RELATED, BUT DIFFERENT, COMMUNITY HEALTH CAUSE. 704950 6592304 7297254 4833278 57480806 18646210 43667874 5003394 3435279 1568115 25620016 18698724 6921292 14411918 10295532 4116386 63570921 FIXED INCOME FUNDS 34546139 F EQUITY FUNDS 120025607 F SHORT-TERM INVESTMENTS 171496 F ALTERNATIVE INVESTMENTS 27831171 F 182574413 0 0 X SCHEDULE D PART X, LINE 2 THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE RECEIVED A CONSOLIDATED AUDITED FINANCIAL STATEMENT FOR THE TAX YEAR ENDING JUNE 30, 2016 THAT WAS PREPARED IN ACCORDANCE WITH GAAP. A FIN 48 FOOTNOTE TO THE AUDITED FINANCIAL STATEMENTS DISCLOSED "ITXM'S CONSOLIDATED BALANCE SHEETS DO NOT INCLUDE ANY LIABILITIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS; FURTHER, ITXM HAS NO UNRECOGNIZED TAX BENEFITS." Central America and the Caribbean Investments 18592795 Europe (Including Iceland and Greenland) Investments 9238376 27831171 27831171 true false true false false false true UNIVERSITY OF PITTSBURGH-DEPT OF MEDICINE 1218 SCAIFE HALL PITTSBURGH PA 15261 250965591 501(C)(3) 3000000 ESTABLISH A HEMOSTASIS AND VASCULAR BIOLOGY INSTITUTE TO FURTHER BASIC AND CLINIC RESEARCH AND EDUCATION REGARDING BLOOD DISEASES WESTERN PA CHAPTER OF THE HEMOPHILIA FDN 20411 RT 19 UNIT 14 CRANBERRY PA 16066 251359331 501(C)(3) 119500 TO IMPROVE THE LIVES OF THE MEMBERS OF THE BLEEDING DISORDERS COMMUNITY THROUGH EDUCATIONAL PROGRAMS, GUIDANCE AND SUPPORT. PATIENT SERVICES INC PO BOX 1602 MIDLOTHIAN VA 22113 541596178 501(C)(3) 30000 PATIENT ASSISTANCE FOR INSURANCE PREMIUMS TO PATIENTS WITH CHRONIC DISEASES FDN FOR WOMEN & GIRLS WITH BLEEDING DISORDERS 11 CLOVERHILL PLACE MONTCLAIR NJ 04042 272456813 501(C)(3) 139430 ENSURE WOMEN AND ADOLESCENT GIRLS WITH BLOOD DISORDERS ARE CORRECTLY DIAGNOSED AND OPTIMALLY TREATED AND MANAGED AT EVERY LIFE STAGE. CHILDREN'S HOSPITAL OF PHILADELPHIA 3501 CIVIC CENTER BLVD PHILA PA 19104 231352166 501(C)(3) 21606 SUPPORT THE ANNUAL EDUCATIONAL MEETING FOR FEDERALLY FUNDED HEMOPHILIA TREATMENT CENTERS. UPMC-UNIVERSITY OF PGH PHY 230 LOTHROP STREET PITTSBURGH PA 15213 252919472 501(C)(3) 209446 SUPPORT SICKLE CELL DISEASE PROGRAM PATIENT TREATMENT EFFORTS ALLEGHENY-SINGER RESEARCH INSTITUTE 320 EAST NORTH AVENUE PITTSBURGH PA 15212 251320493 501(C)(3) 500000 BLOOD PRODUCT RESEARCH INSTITUTE FOR TRANSFUSION MEDICINE PC5 875 GREENTREE RD PGH PA 15220 251562714 501(C)(3) 19447 FELLOWSHIP SALARY REIMBURSEMENT 8 0 PART I LINE 2 - BLOOD SCIENCE FOUNDATON THE SECRETARY/TREASURER FOR THE BOARD OF DIRECTORS OF THE BLOOD SCIENCE FOUNDATION IS RESPONSIBLE FOR OBTAINING DOCUMENTATION FROM THE GRANT RECIPIENT THAT DEMONSTRATES COMPLIANCE WITH THE GRANT AGREEMENT. ANY FINDINGS OF NON-COMPLIANCE WILL BE REPORTED TO THE BOARD AT ITS NEXT REGULARLY SCHEDULED MEETING WITH THE SECRETARY/TREASURER'S RECOMMENDATION FOR CORRECTIVE ACTION. LINE 2 - HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA AS PART OF ITS ANNUAL BUDGET PROCESS, THE HEMOPHILIA CENTER DETERMINES APPROPRIATE LEVELS OF COMMUNITY SUPPORT BASED ON REQUESTS RECEIVED BY 501(C)(3) ORGANIZATIONS WHO SHARE SIMILAR MISSIONS IN SERVICING THE NEEDS OF THE BLEEDING DISORDERS COMMUNITY. THE CENTER REVIEWS ALL REQUESTS ALONG WITH PRIOR FUNDING REPORTS FROM THE ORGANIZATIONS WHICH ARE PRESENTED TO THE CENTER PRESIDENT/MEDICAL DIRECTOR AND EXECUTIVE DIRECTOR AND THEN SUBSEQUENTLY VOTED ON BY THE BOARD DURING THE ADOPTION OF THE ANNUAL BUDGET. EACH FUNDING REQUEST REQUIRES THE RECIPIENT ORGANIZATION TO SIGN A FINANCIAL ASSISTANCE AGREEMENT WHICH STIPULATES THE DURATION OF THE FUNDING, THE AMOUNT OF THE FUNDING, THE INTENDED USE OF THE FUNDS, AND REQUIRES AN ACCOUNTING OF THE UTILIZED FUNDS. X true true false true false false false false false false false JAMES P COVERT CENTRAL BLOOD BANK, PRES & CEO 0 468796 0 149600 0 0 0 136141 0 32652 0 787189 0 0 MARK J GIAQUINTO CENTRAL BLOOD BANK SECY/TREAS 0 275662 0 71800 0 0 0 65716 0 22540 0 435718 0 0 DIANE MERKT CENTRAL BLOOD BANK VP 0 232422 0 49200 0 0 0 60133 0 11319 0 353074 0 0 LINDA HAHN ITXM CLINICAL SVCS VICE PRES 206353 0 47700 0 29643 0 154711 0 21580 0 459987 0 0 0 ANDREA CORTESE HASSETT PHD ITXM DIAGNOSTICS VICE PRES 190409 0 42900 0 25 0 91758 0 24342 0 349434 0 0 0 JAMES FITZGERALD CBBVP & COO (THROUGH 06/15) 0 145885 0 0 0 23414 0 -18187 0 14963 0 166075 0 0 MONA PAPARI LIFESOURCE MEDICAL DIRECTOR 244992 0 0 0 0 0 14415 0 1218 0 260625 0 0 0 MICHELE TYSARCZYK CENTRAL BLOOD BANK EXEC DIR 153191 0 12392 0 2917 0 31550 0 22410 0 222460 0 0 0 CHELSEA SHEPPARD MD VIRGINIA BLOOD SVCS MED DIR 198375 0 0 0 0 0 0 0 3224 0 201599 0 0 0 ELEANOR BOENS VIRGINIA BLOOD SVCS HR DIR 152713 0 12158 0 0 0 0 0 7807 0 172678 0 0 0 JASON CRANE LS ASSOCIATE MEDICAL DIRECTOR 178116 0 0 0 0 0 12035 0 26976 0 217127 0 0 0 PART I PART I LINE 1A THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE DO NOT REIMBURSE FOR FIRST CLASS TRAVEL BUT SOMETIMES UPGRADES ARE MADE FOR BOARD MEMBERS AND SENIOR MANAGEMENT USING DISCOUNT OR FREQUENT FLIER COUPONS; EXECUTIVE/SOCIAL DUES ARE PAID FOR THE CEO AND CFO; AIRLINE AND EXECUTIVE CLUB DUES ARE PAID FOR SOME OF SENIOR MANAGEMENT. PART I LINE 3 THE INSTITUTE FOR TRANSFUSION MEDICINE, THE PARENT COMPANY, ESTABLISHES THE COMPENSATION OF THE CEO USING THE SIX MEASURES DESCRIBED IN PART I, LINE 3. PART I, LINE 4B JAMES COVERT $112,527; MARK GIAQUINTO $46,819; DIANE MERKT $40,148; JAMES FITZGERALD-TERMINATED 06/15 $(26,107); ANDREA CORTESE-HASSETT $33,384; LINDA HAHN RECEIVED A REQUIRED NON QUALIFIED PLAN DISTRIBUTION PAYMENT OF $29,643. PART II PART I, LINES 5 AND 6 AND PART II B(II) PERFORMANCE BASED BONUSES ARE PAID TO SENIOR AND MIDDLE MANAGEMENT ACCORDING TO CRITERIA WHICH IS ESTABLISHED AT THE BEGINNING OF THE YEAR BY THE COMPENSATION COMMITTEE OF THE BOARD. THE CRITERIA INCLUDES THE ORGANIZATION'S OVERALL OPERATING AND FINANCIAL RESULTS ALONG WITH ACTIVITY AND QUALITY METRICS. X OIL CHANGE VOUCHERS 3 147080 FMV X GIFT CARDS/CERTIFICATES 15 122735 FMV X OTHER 9 24375 FMV false true false PART III 4D OTHER PROGRAM SERVICES BLOOD SCIENCE FOUNDATION (BSF) SUPPORTS ITXM AND ITS SUBSIDIARIES BY ASSISTING IN THE ADVANCEMENT OF MEDICAL EDUCATION, RESEARCH AND INVESTIGATION AND PROVIDING FUNDS TO FURTHER THE BUILDING, ESTABLISHMENT, ORGANIZATION, EQUIPMENT, MANAGEMENT AND MAINTENANCE OF THE FACILITIES. BSF ALSO MAKES GRANTS TO INDEPENDENT OUTSIDE INVESTIGATORS FOR HEALTH RELATED RESEARCH AND DEVELOPMENT. PART VI, SECTION A, LINE 6 THE INSTITUTE FOR TRANSFUSION MEDICINE IS THE SOLE CORPORATE MEMBER OF EACH ORGANIZATION THAT IS INCLUDED IN THIS FORM 990. PART VI, SECTION A, LINES 7A & 7B THE INSTITUTE FOR TRANSFUSION MEDICINE, AS THE SOLE CORPORATE MEMBER OF EACH ORGANIZATION INCLUDED IN THE GROUP RETURN, HAS THE POWER TO CARRY OUT THE LISTED FUNCTIONS WITH RESPECT TO EACH ORGANIZATION INCLUDED IN THE GROUP RETURN: (A) OVERSEE AND MONITOR THE CONDUCT OF THE BUSINESS AND ACTIVITIES TO DETERMINE WHETHER THEY ARE PROPERLY MANAGED IN RELATION TO THE CHARITABLE, COMMUNITY SERVICE AND STRATEGIC MISSION AND GOALS OF THE CORPORATION AND IN COMPLIANCE WITH APPLICABLE LAWS, REGULATIONS AND BOARD-MANDATED POLICIES; (B) EXERT FINAL DECISION-MAKING AUTHORITY OVER CHOICES RELATING TO ORGANIZATIONAL STRUCTURE, STRATEGIC GOALS AND ECONOMIC OBJECTIVES, MAJOR OPERATING POLICIES AND SIGNIFICANT FINANCIAL ACCOUNTING PRINCIPLES AND PRACTICES; (C) SELECT, REGULARLY EVALUATE, FIX THE COMPENSATION OF AND (WHEN APPROPRIATE) REPLACE THE SENIOR EXECUTIVE OFFICERS AND THE MEMBERS OF THE BOARD; (D) SELECT EXTERNAL CERTIFIED PUBLIC ACCOUNTANTS TO CONDUCT AN ANNUAL EXAMINATION AND AUDIT OF THE CORPORATION'S FINANCIAL STATEMENTS; (E) SELECT CORPORATE LEGAL COUNSEL TO ADVISE THE BOARD IN PERFORMING ITS FUNCTIONS AND THE MEMBERS OF THE BOARD IN PERFORMING THEIR FIDUCIARY DUTIES; (F) REVIEW AND APPROVE MAJOR PLANS, COMMITMENTS AND INITIATIVES, INCLUDING ACQUISITIONS, DIVESTITURES AND CAPITAL EXPENDITURE PROGRAMS AND PROJECTS, PROPOSED BY THE SENIOR EXECUTIVE OFFICERS, ALL WITH DUE REGARD FOR POTENTIAL BENEFITS AND RISKS RELATIVE TO THE CORPORATION'S CHARITABLE, COMMUNITY SERVICE AND STRATEGIC MISSION AND GOALS; (G) PROVIDE ADVICE AND GUIDANCE TO THE SENIOR EXECUTIVE OFFICERS IN CONNECTION WITH THE BUSINESS AND ACTIVITIES AND ASSIST IN GAINING ACCESS TO KEY EXTERNAL RESOURCES FOR ADVANCEMENT OF THE CHARITABLE AND COMMUNITY SERVICE MISSION; AND (H) EXERCISE SUCH OTHER POWERS AS HAVE BEEN DELEGATED AND PERFORM SUCH OTHER FUNCTIONS AS ARE PRESCRIBED BY APPLICABLE LAWS AND REGULATIONS. PART VI, SECTION B, LINE 11 THE 990 IS COMPLETED BY MANAGEMENT AND IS REVIEWED BY AN EXTERNAL, INDEPENDENT ACCOUNTING FIRM. THE 990 HAS BEEN REVIEWED BY THE PARENT'S EXECUTIVE LEADERSHIP AND A COPY HAS BEEN SENT TO THE BOARD GOVERNING THE SUBSIDIARIES FOR THEIR REVIEW PRIOR TO FILING. PART VI, SECTION B, LINE 12C ALL DIRECTORS, OFFICERS AND KEY EMPLOYEES ARE REQUIRED TO SUBMIT A FORM ANNUALLY DISCLOSING ANY ACTUAL OR POSSIBLE CONFLICTS OF INTEREST. THE FORMS ARE REVIEWED BY THE GOVERNANCE COMMITTEE WHICH THEN DETERMINES WHETHER A CONFILCT EXISTS. ANY PERSON DEEMED TO HAVE A CONFLICT DURING THE YEAR IS PROHIBITED FROM PARTICIPATING IN DELIBERATIONS AND DECISIONS REGARDING CONFLICTED TRANSACTIONS. PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE OF THE INSTITUTE FOR TRANSFUSION MEDICINE BOARD OF DIRECTORS RETAINS AN INDEPENDENT, THIRD-PARTY COMPENSATION CONSULTANT TO ANNUALLY REVIEW AND ANALYZE THE MARKET COMPETITIVENESS, REASONABLENESS AND APPROPRIATENESS OF EXECUTIVE PAY AT ITXM AND ITS SUBSIDIARIES. THIS ANALYSIS INCLUDES THE CEO, EXECUTIVES REPORTING DIRECTLY TO THE CEO AND EMPLOYEES WHOSE BASE SALARIES EXCEED THE LOWEST PAID DIRECT REPORT TO THE CEO. AT THE REQUEST OF THE COMPENSATION COMMITTEE, THE COMPENSATION CONSULTANT CONDUCTS AN ANNUAL COMPETITIVE ANALYSIS THAT FOCUSES ON BASE PAY, SHORT-TERM INCENTIVE PAY AND LONG-TERM INCENTIVE PAY AND CONDUCTS A TOTAL COMPENSATION ANALYSIS INCLUSIVE OF INDIRECT COMPENSATION AND OTHER NON-CASH COMPENSATION ELEMENTS EVERY THREE TO FIVE YEARS DEPENDING ON REGULATORY, LEGISLATIVE AND EXTERNAL ACTIONS AND TRENDS. THE COMPETITIVE ANALYSES ARE CONDUCTED ACCORDING TO A BOARD-APPROVED EXECUTIVE COMPENSATION STRATEGY AND MARKET ANALYSIS METHODOLGY. THIS PROCESS WAS COMPLETED IN 2016. PART VI, SECTION C LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. GEISINGER BLOOD CTR PC5 875 GRNTREE RD PGHPA 15220 PITTSBURGH PA 15220 364718005 BLOOD BANK PA NA ITM HOLDINGS LTD FIVE PARKWAY CENTER 875 GREENTREE R PGH PA 15220 251736459 INVESTMENT SU PA NA C CORP TXM CONSULTING FIVE PARKWAY CENTER 875 GREENTREE R PGH PA 15220 251736461 CONSULTING PA NA C CORP false true false false false false false false true false true true false false false false true true LIFESOURCE GEISINGER BLOOD CENTER L 4897569 FMV INSTITUTE FOR TRANSFUSION MEDICINE S 9585000 FMV INSTITUTE FOR TRANSFUSION MEDICINE R 10665811 FMV INSTITUTE FOR TRANSFUSION MEDICINE J 622170 FMV INSTITUTE FOR TRANSFUSION MEDICINE M 22527593 FMV INSTITUTE FOR TRANSFUSION MEDICINE B 19447 FMV PART IV EFFECTIVE JULY 2015, ITXM HAS RECEIVED FINAL APPROVAL FOR THE DISSOLUTION OF ITM HOLDINGS AND ITS SUBSIDIARY, TXM CONSULTING. CENTRAL BLOOD BANK 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251055312 INST LIFESOURCE 5 PARKWAY CENTER 875 GREENTREE RD pittsburgh PA 15220 363492969 INST ITXM CLINICAL SERVICES 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251839168 INST HEMOPHILIA CENTER OF WESTERN PA 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251562716 INST BLOOD SCIENCE FOUNDATION 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251562715 BLOO itxm diagnostics inc 5 PARKWAY CENTER 875 GREENTREE RD pittsburgh PA 15220 030497690 INST VIRGINIA BLOOD SERVICES 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 540959121 INST